ATPC Agape ATP Corp
Services-Health Services · Nasdaq · SEC CIK 1713210 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-47.0%
TTM net income YoY76.2%
TTM EPS YoY98.5%
Revenue 3-yr CAGR-18.0%
Net income 3-yr CAGR—
Margins
Gross margin52.1%
Operating margin-372.9%
Net margin-82.9%
FCF margin—
EBITDA margin-372.4%
Returns
ROE-2.9%
ROA-2.6%
ROIC (approx.)-10.4%
Asset turnover0.03x
Leverage & solvency
Liabilities / assets13.2%
Debt / equity0.00x
Current ratio7.59x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.05x
Accruals ratio0.1%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $4,798 | $109,098 | $273,658 | $399,133 | $370,593 | $465,499 | $289,037 | $359,776 |
| Cost of revenue | $379 | $1,923 | $114,249 | $165,192 | $16,726 | $141,661 | $132,751 | $181,794 |
| Gross profit | $4,419 | $11,770 | $159,409 | $233,941 | $92,298 | $65,368 | $156,286 | $177,982 |
| SG&A expense | $381,842 | $529,033 | $794,712 | $1.45M | $587,175 | $611,020 | $805,693 | $981,985 |
| Operating income | -$407,207 | -$550,975 | -$677,372 | -$1.30M | -$581,154 | -$621,534 | -$720,404 | -$848,109 |
| Pretax income | -$83,478 | $83,591 | -$340,906 | -$374,983 | -$574,013 | -$607,825 | -$712,919 | -$835,464 |
| Income tax | $206 | — | — | $1,089 | $1,196 | — | — | -$8,869 |
| Net income | -$83,684 | $149,437 | -$340,906 | -$376,937 | -$595,370 | -$623,246 | -$712,919 | -$808,439 |
| EBITDA | -$406,763 | -$550,481 | -$675,900 | -$1.30M | -$579,938 | -$618,437 | -$707,835 | -$827,950 |
| EPS (basic) | -0.08 | 0.15 | -0.33 | — | -0.58 | -0.62 | -3.63 | — |
| EPS (diluted) | -0.08 | 0.15 | -0.33 | — | -0.58 | -0.62 | -3.63 | — |
| Weighted avg. shares (diluted) | 1.00M | 1.00M | 1.00M | — | 1.00M | 1.00M | 192,421 | — |
| Banking | ||||||||
| Deposits | $47,538 | $45,480 | $209,162 | $89,651 | $125,148 | $202,407 | $572,440 | $2.03M |
| Balance sheet | ||||||||
| Cash & equivalents | $47,538 | $45,480 | $220,779 | $89,651 | $102,773 | $197,041 | $578,794 | $1.99M |
| Receivables | — | — | $4,366 | $4,023 | $7,437 | $23,920 | $41,440 | $53,651 |
| Inventory | $21,184 | $21,678 | $24,788 | $26,148 | $39,886 | $36,298 | $36,705 | $46,347 |
| Current assets | $25.13M | $24.83M | $24.65M | $24.29M | $24.07M | $24.35M | $24.78M | $2.78M |
| PP&E, net | $3,615 | $4,071 | $13,228 | $5,140 | $15,122 | $16,988 | $19,810 | $31,463 |
| Intangibles | — | — | $8,294 | $1 | $10,289 | $11,438 | $12,043 | $13,082 |
| Total assets | $25.32M | $25.03M | $24.91M | $24.59M | $24.25M | $24.57M | $25.18M | $3.24M |
| Current liabilities | $3.31M | $2.94M | $2.74M | $2.05M | $1.49M | $1.20M | $1.00M | $1.12M |
| Total liabilities | $3.34M | $2.97M | $2.84M | $2.17M | $1.59M | $1.31M | $1.15M | $1.31M |
| Shareholders' equity | $21.98M | $22.05M | $22.12M | $22.46M | $22.83M | $23.43M | $24.05M | $1.93M |
| Shares outstanding | 1.00M | 1.00M | 1.00M | 1.00M | 50.01M | 50.01M | 50.01M | 79,781 |
| Cash flow statement | ||||||||
| Operating cash flow | $30,406 | -$110,318 | -$394,770 | -$208,348 | -$256,742 | -$494,458 | -$1.45M | -$645,335 |
| Capital expenditure | — | — | — | — | — | — | $649 | — |
| Free cash flow | — | — | — | — | — | — | -$1.45M | — |
| Investing cash flow | -$5,208 | — | — | -$382 | -$7 | -$11 | -$23.00M | -$1,439 |
| Financing cash flow | -$27,901 | -$82,429 | $496,474 | $201,637 | $181,331 | $121,020 | $22.99M | -$5,165 |
| Depreciation & amortization | $444 | $494 | $1,472 | $1,677 | $1,216 | $3,097 | $12,569 | $20,159 |
Free plan shows the latest 8 periods; Pro shows all 40 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.